Events

Seas to skies conference: greening ports and airports in the EU
DEC
Tue
03
DEC
Wed
04

This was 7 months ago

Location

Brussels Airport and Antwerp

skyhall @Brussels Airport and Elizabeth hall in Antwerp
Programmes
Climate, Energy, Mobility Green Deal

During this conference you can gather knowledge about the findings and learnings from five Green Deal Call funded projects from the port and airport industry. The projects are called MAGPIE, OLGA, PIONEERS, STARGATE and TULIPS and are all dedicated to reducing GHG emission in ports and airports.

You can find more information and registration details on this website

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.